首页> 外文期刊>Reports >The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
【24h】

The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis

机译:抗胰腺炎中患癌的抗性高钙血症和胰腺炎患者的管理

获取原文
       

摘要

We present a 31-year-old female who presented to the general surgical take with epigastric pain associated with a raised amylase and corrected calcium on admission. Computed tomography confirmed acute pancreatitis and also demonstrated a 15 cm liver tumour. She was subsequently diagnosed with cancer of unknown primary with liver metastases. The patients pancreatitis symptoms improved with conservative management, but her calcium proved quite resistant to basic measures. Further input was sought from the medical on-call endocrinology and oncology teams to help manage this patients hypercalcaemia, which included pamidronate, zolendronate, and denusomab, but ultimately it only improved significantly following chemotherapy. This case to our knowledge is the only one of its kind and highlights the importance of early multidisciplinary team involvement across specialties to help manage complex patients.
机译:我们展示了一名31岁的女性,展示了一般的手术,伴有与凸起的淀粉酶相关的外延疼痛和矫正钙的入学钙。计算机断层扫描证实急性胰腺炎,也证明了15厘米的肝肿瘤。随后被诊断出患有未知初级原发性肝转移的癌症。患者胰腺炎症状随着保守的管理而改善,但她的钙证明了对基本措施的耐受性。来自医疗接受呼叫内分泌学和肿瘤学团队寻求进一步的投入,以帮助管理该患者高钙血症,其中包括Pamidronate,Zolendronate和Denusomab,但最终它仅在化疗后显着改善。我们的知识案例是唯一一个,并突出了早期多学科团队参与的重要性,以帮助管理复杂患者。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号